High-expression technology through proprietary sequence optimization
Proprietary genetic optimization maximizes target protein expression in plant cells for industrial-scale production.
Plant molecular farming biotech platforms and core technologies.
Proprietary genetic optimization maximizes target protein expression in plant cells for industrial-scale production.
Homozygous lines and seed bank systems enable consistent raw material production at scale.
Quality systems from cultivation through preclinical research, aligned with GACP guidelines.
Beyond traditional animal cell culture, plant-based systems deliver safer, scalable target protein production with reduced pathogen risk.
biotech.pmf.card1.subtitle
Produce proteins without animal-derived pathogens.
biotech.pmf.card2.subtitle
Long-term storage in seed form ensures supply stability.
Protein solution
Developing proteins applicable to respiratory disease prevention.
Ingredient solution
Bio-ingredients for advanced medical cosmetic applications.
Nicotiana benthamiana
Leaf Platform optimized for rapid production
Oryza sativa
Rice Platform with stable long-term storage
Transactiva platform technology supports protein drug and material development across rare disease, immunology, and infection prevention.
Supporting recombinant protein development for rare metabolic disorders.
Applicable to biopharmaceutical development in oncology and autoimmunity.
Supporting protein material development for respiratory infection prevention.
Bio-ingredients for medical cosmetic applications.
The project applies Plant Molecular Farming technology to the diagnostic sector, aiming to produce recombinant antibodies in plants and validate their use in diagnostic kits.
New Recombinant Enzymes for the Management of Irritated Skin in the Elderly
CERAMIDE Creation of a Recombinant Enzyme as an “Active BioMimetic Ingredient” for Dermocosmetics
Recombinant Proteins as Bioactives for Alopecia and Functional Trichological Cosmeceuticals”